Irinotecan EP Impurity G;IRINOTECAN EP IMPURITY G (7,11-DIETHYL-10-HYDROXY CAMPTOTHECIN);(S)-4,8,11-Triethyl-4,9-dihydroxy-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione;(S)-4,8,11-triethyl-4,9-dihydroxy-;1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4,8,11-triethyl-4,9-dihydroxy-, (4S)-;(S)-4,8,11-triethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione? (Irinotecan Impurity）;Irinotecan EP Impurity G/ Irinotecan Related Compound G (7,11-Diethyl-10-hydroxycamptothecin/ 8,11-Diethyl-9-Hydroxy Camptothecin);(4S)-4,8,11-Triethyl-4,9-dihydroxy-1H-pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
